VRAX – virax biolabs group limited (US:NASDAQ)
Stock Stats
News
Virax Biolabs Group (NASDAQ:VRAX) was upgraded by analysts at Zacks Research to a "hold" rating.
Virax Biolabs Group (NASDAQ:VRAX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Virax Biolabs Group (NASDAQ:VRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock, down previously from $3.00.
Form 3 Virax Biolabs Group Ltd For: Mar 18 Filed by: McCracken Nigel William
Form 6-K Virax Biolabs Group Ltd For: Mar 18
Form 3 Virax Biolabs Group Ltd For: Mar 18 Filed by: Foster James Alexander Cunliffe
Form 3 Virax Biolabs Group Ltd For: Mar 18 Filed by: Davis Jason
Form 3 Virax Biolabs Group Ltd For: Mar 18 Filed by: Norton Evan Michael
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.